TY  - JOUR
AU  - Gómez-Gómez, Enrique
AU  - Carrasco-Valiente, Julia
AU  - Campos-Hernández, Juan Pablo
AU  - Blanca-Pedregosa, Ana Maria
AU  - Jiménez-Vacas, Juan Manuel
AU  - Ruiz-García, Jesus
AU  - Valero-Rosa, Jose
AU  - Luque, Raul Miguel
AU  - Requena-Tapia, María José
PY  - 2018
DO  - 10.1111/jcmm.13994
UR  - http://hdl.handle.net/10668/13207
T2  - Journal of cellular and molecular medicine
AB  - Recently, the influence that metabolic syndrome (MetS), hormonal alterations and inflammation might have on prostate cancer (PCa) risk has been a subject of controversial debate. Herein, we aimed to investigate the association between MetS-components,...
LA  - en
KW  - C-reactive protein
KW  - inflammation
KW  - metabolic syndrome
KW  - significant prostate cancer
KW  - testosterone
KW  - Aged
KW  - Biopsy
KW  - C-Reactive Protein
KW  - Humans
KW  - Inflammation
KW  - Male
KW  - Metabolic Syndrome
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Odds Ratio
KW  - Prospective Studies
KW  - Prostate
KW  - Prostatic Neoplasms
KW  - Risk Factors
KW  - Testosterone
TI  - Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer.
TY  - research article
VL  - 23
ER  -